A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped ...

April 21 (Reuters) - Merck and Eisai's experimental combination treatments failed to significantly improve survival or reduce ...

Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ ...

Islatravir-doravirine matched alternate regimens in two phase III trials ...

A post hoc analysis evaluates zanubrutinib vs acalabrutinib-venetoclax in treatment naive chronic lymphocytic leukemia using indirect comparisons of data from two phase 3 trials.

America's Test Kitchen’s Dan Souza prepares a vibrant beet salad with spiced yogurt and peppery watercress for balance and ...

Interim results from two investigator-initiated trials revealed insights into the role of injectables to address the ...

The trial enrolled 210 patients in the darovasertib combination arm and 103 in the ICT arm.

FDA accepted an RTOR sBLA and granted priority review for zanidatamab-hrii combinations as first-line therapy in HER2+ ...

Invincible Vs isn't always the smoothest experience, but it has a solid and chaotic mechanical foundation with tons of ...